Arcturus Therapeutics is trading at $12.00, up +10.40%, with the broad biotech-sector rally the clearest available catalyst. - XBI was up 2.08% pre-market; the sector context cited strong Amgen results and a positive industry outlook. - No new company-specific announcement was identified for November 5. - Arcturus Therapeutics is scheduled to release third-quarter results after the market close, with a call at 4:30 p.m. ET.